• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.

作者信息

Antonelli Guido, Turriziani Ombretta, Pierangeli Alessandra, d'Ettorre Gabriella, Galardo Gioacchino, Pugliese Francesco, Mastroianni Claudio M, Scagnolari Carolina

机构信息

Laboratory of Microbiology and Virology, Department of Molecular Medicine, Institute Pasteur Italia, Italy; University Hospital "Policlinico Umberto I", Italy.

Laboratory of Microbiology and Virology, Department of Molecular Medicine, Institute Pasteur Italia, Italy; University Hospital "Policlinico Umberto I", Italy.

出版信息

J Clin Virol. 2020 Jul;128:104450. doi: 10.1016/j.jcv.2020.104450. Epub 2020 May 20.

DOI:10.1016/j.jcv.2020.104450
PMID:32464309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7237947/
Abstract
摘要

相似文献

1
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.在感染新型冠状病毒2（SARS-CoV-2）患者的呼吸道拭子中可检测到I型干扰素。
J Clin Virol. 2020 Jul;128:104450. doi: 10.1016/j.jcv.2020.104450. Epub 2020 May 20.
2
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
3
COVID-19, Mitochondria, and Interferon.新型冠状病毒肺炎、线粒体与干扰素
J Interferon Cytokine Res. 2020 Sep;40(9):466-467. doi: 10.1089/jir.2020.0112. Epub 2020 Jul 28.
4
Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2".对“法匹拉韦用于感染严重急性呼吸综合征冠状病毒2患者的剂量依据”的回应
Clin Pharmacol Ther. 2020 Aug;108(2):190. doi: 10.1002/cpt.1878. Epub 2020 May 21.
5
The index case of SARS-CoV-2 in Scotland.苏格兰首例 SARS-CoV-2 病例。
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.022. Epub 2020 Mar 21.
6
Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2.法匹拉韦用于感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）患者的剂量依据。
Clin Pharmacol Ther. 2020 Aug;108(2):188. doi: 10.1002/cpt.1877. Epub 2020 May 21.
7
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
8
From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.从严重急性呼吸综合征冠状病毒到严重急性呼吸综合征冠状病毒2：法医传染病尸检的应对与挑战
Fa Yi Xue Za Zhi. 2020 Feb;36(1):1-3. doi: 10.12116/j.issn.1004-5619.2020.01.001. Epub 2020 Feb 25.
9
Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis.评价 I 型干扰素治疗临床人类冠状病毒（HCoVs）感染的安全性、疗效、耐受性和治疗相关结局：更新的关键性系统评价和荟萃分析。
Int Immunopharmacol. 2020 Sep;86:106740. doi: 10.1016/j.intimp.2020.106740. Epub 2020 Jun 25.
10
Acute kidney injury in SARS-CoV-2 infected patients.新型冠状病毒肺炎（COVID-19）感染患者的急性肾损伤
Crit Care. 2020 Apr 16;24(1):155. doi: 10.1186/s13054-020-02872-z.

引用本文的文献

1
Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System.血脑屏障损伤是SARS-CoV-2感染中枢神经系统的关键因素。
Exp Neurobiol. 2022 Aug 31;31(4):270-276. doi: 10.5607/en21049.
2
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.来自 COVID-19 患者的抗 IFN-α/-ω 中和抗体与 IFN 反应下调和疾病严重程度的实验室生物标志物相关。
Eur J Immunol. 2022 Jul;52(7):1120-1128. doi: 10.1002/eji.202249824. Epub 2022 Apr 28.
3
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.I 型和 III 型干扰素的延迟诱导介导了鼻腔上皮细胞对 SARS-CoV-2 的易感性。
Nat Commun. 2021 Dec 7;12(1):7092. doi: 10.1038/s41467-021-27318-0.
4
Type I Interferons in COVID-19 Pathogenesis.1型干扰素在新冠病毒疾病发病机制中的作用
Biology (Basel). 2021 Aug 26;10(9):829. doi: 10.3390/biology10090829.
5
analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染细胞中长链非编码RNA表达改变及其受信号转导和转录激活因子1（STAT1）、信号转导和转录激活因子3（STAT3）以及干扰素调节因子调控的分析
Heliyon. 2021 Mar;7(3):e06395. doi: 10.1016/j.heliyon.2021.e06395. Epub 2021 Feb 27.
6
Manganese nanodepot augments host immune response against coronavirus.锰纳米储库增强宿主对冠状病毒的免疫反应。
Nano Res. 2021;14(5):1260-1272. doi: 10.1007/s12274-020-3243-5. Epub 2020 Dec 29.
7
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.严重新型冠状病毒肺炎/艾滋病病毒-1合并感染中I型干扰素反应和T细胞活化的分析：一例报告
Medicine (Baltimore). 2020 Sep 4;99(36):e21803. doi: 10.1097/MD.0000000000021803.

本文引用的文献

1
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
2
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.SARS-CoV-2 受体 ACE2 是人类气道上皮细胞中的一种干扰素刺激基因，可在组织中的特定细胞亚群中检测到。
Cell. 2020 May 28;181(5):1016-1035.e19. doi: 10.1016/j.cell.2020.04.035. Epub 2020 Apr 27.
3
Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒2对干扰素表达的弱诱导作用支持了干扰素λ治疗早期2019冠状病毒病的临床试验。
Clin Infect Dis. 2020 Sep 12;71(6):1410-1412. doi: 10.1093/cid/ciaa453.
4
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
5
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.SARS-CoV-2 和 SARS-CoV 在人肺中的比较复制和免疫激活特征：一项具有 COVID-19 发病机制意义的离体研究。
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.
6
Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.呼吸道合胞病毒-A 基因型 ON1 引起毛细支气管炎的干扰素基因表达差异。
Med Microbiol Immunol. 2020 Feb;209(1):23-28. doi: 10.1007/s00430-019-00633-6. Epub 2019 Sep 4.
7
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.I型干扰素与HIV：抗病毒活性、免疫病理发生与微生物群之间的微妙平衡
Cytokine Growth Factor Rev. 2018 Apr;40:19-31. doi: 10.1016/j.cytogfr.2018.03.003. Epub 2018 Mar 16.